Aa
A
A
A
Close
Hepatitis C Community
13.3k Members
Avatar universal

EASL 2013 International Liver Congress in Amsterdam

Hi All,

Here are some key pieces of information presented at the EASL 2013 International Liver Congress in Amsterdam these past few days:

Gilead: reported results of four phase 3 trials, Neutrino, Fission, Positron, and Fusion.  Neutrino: g 1, 4, 5, 6, treatment naive, sofosbuvir + RBV + Peg-IFN for 12 wks, 90% SVR12; Fission:  g 2/3, treatment naive, sofosbuvir + RBV for 12 wks (67% SVR12) or Peg-IFN + RBV for 24 wks (67% SVR12); Positron: G 2/3, IFN intolerant, ineligible, or unwilling:  sofosbuvir + RBV for 12 wks (78% SVR 12) or sofosbuvir + RBV for 12 wks (50% SVR12); Fusion g2/3 treatment-exp:  sofosbuvir + RBV for 16 wks (73% SVR12).

Boehringer Ingelheim: reported results from one phase 3 trial, STARTVerso:  g 1, treatment naive, faldaprevir + INF (80% SVR12).

Janssen R & D Ireland:  reported results of two phase 3 trials, Quest 1 and Quest 2:  g 1 & 2, treatment naive, simeprevir, CC=94% SVR12, CT=76% SVR12, TT=65% SVR12.

AbbVie:  reported results of phase 2 trial.  12 wk regimen of 3 trial drugs combined with RBV (90% SVR12).

I will post some articles on my journals.

Advocate1955
25 Responses
Avatar universal
Thanks for posting Advocate...I am headed to your journals

Jules
Avatar universal
Thanks Advocate, just a quick glance but this did jump out.

"Patient response rates to hepatitis C therapy can be variable, depending on factors such as viral genotype and subtype, and liver fibrosis. Patients with genotype 1a, IL28B genotype TT and METAVIR scores of F3 and F4 can be particularly challenging to cure," said Maria Beumont, M.D., medical leader for simeprevir, Janssen. "Janssen is committed to advancing hepatitis C therapy for even the most difficult-to-cure patients."
--------------------
Mainly this comment......  and METAVIR scores of F3 and F4 can be particularly challenging to cure
Avatar universal
Yes, the news for treatment experienced, g1s, with advanced liver disease is yet to be seen.
Advocate1955
1815939 tn?1377995399
Thanks for posting that. I am headed to your journals too.
Avatar universal
"Patient response rates to hepatitis C therapy can be variable, depending on factors such as viral genotype and subtype, and liver fibrosis"

**************
This quote that Cando posted above is so vague and generalized. "variable" can have so many definitions.  And I am sure there are many additional factors to take into consideration besides the obvious in what was quoted in the statement.  Several members have pre-existing conditions and additional dx besides Hep C.  As Ad said "experienced G1's w/ advanced liver disease is yet to be seen.....This tx could be a long wait.  

I have to say I don't understand why some people F2-3 (maybe could be more of an F3 who really knows) are not treating now.JMHO
Avatar universal
I agree. No one knows how long before transition from one stage to another and it will still be awhile for new treatments for cirrhotics.
advocate1955
Avatar universal
I am just not excited about these results for genotype 2 and 3 treatment naives, theres been so much hype here and for what, these results?

"Fission:  g 2/3, treatment naive, sofosbuvir + RBV for 12 wks (67% SVR12) or Peg-IFN + RBV for 24 wks (67% SVR12); Positron: G 2/3, IFN intolerant, ineligible, or unwilling:  sofosbuvir + RBV for 12 wks (78% SVR 12) or sofosbuvir + RBV for 12 wks (50% SVR12); Fusion g2/3 treatment-exp:  sofosbuvir + RBV for 16 wks (73% SVR12)."
Avatar universal
I agree Cando.  I would not gamble on those %'s.  And I really don't like the tx duration.  Maybe if they doubled the length of tx for each trial the %'s may improve....just a thought
1815939 tn?1377995399
I agree with everyone above. While we would all like to see and we hope to see new and easier treatments soon, for some people, waiting for them may cost them their health and/or their lives. I guess that's why all of us took the plunge and treated when we did.
1747881 tn?1546179478
Definitely doesn't live up to the hype IMO, 90% for G1 naive's in 12 weeks is pretty good but still got the good old inf/riba though  
1747881 tn?1546179478
And yes I am glad I jumped in to tri tx with both feet and SVR'd at late stage 3
Avatar universal
            i was talking with a friend who is being seen at mayo, and i have kaiser.  both facilities have stopped using incivek, and vic.  i have not checked this out yet but she said both inc/vic have black box warnings on them.  

           the new geno 1 tx will not help many, and geno 3 should have interferon(my opinion only).  not very impressive.  its time to stop paying rent on that warehouse. haha
                                                       barry
Have an Answer?
Top Hepatitis Answerers
317787 tn?1473362051
DC
683231 tn?1467326617
Auburn, WA
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Answer a few simple questions about your Hep C treatment journey.

Those who qualify may receive up to $100 for their time.
Explore More In Our Hep C Learning Center
image description
Learn about this treatable virus.
image description
Getting tested for this viral infection.
image description
3 key steps to getting on treatment.
image description
4 steps to getting on therapy.
image description
What you need to know about Hep C drugs.
image description
How the drugs might affect you.
image description
These tips may up your chances of a cure.
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Here’s how your baby’s growing in your body each week.
These common ADD/ADHD myths could already be hurting your child
This article will tell you more about strength training at home, giving you some options that require little to no equipment.
In You Can Prevent a Stroke, Dr. Joshua Yamamoto and Dr. Kristin Thomas help us understand what we can do to prevent a stroke.
Smoking substitute may not provide such a healthy swap, after all.